Bharat Biotech announced the successful recruitment of 23,000 volunteers and continued progress towards achieving the goal of 26,000 participants for the phase 3 clinical trial of its Covaxin coronavirus vaccine at multiple sites in India, the ANI news agency said citing the pharmaceutical firm on Saturday. The announcement came hours …
Read More »India rehearses for massive Covid vaccination campaign | India News
NEW DELHI: India conducted a massive nationwide drill on the administration of the Covid-19 vaccine on Saturday at 286 session sites spread across 125 districts. The exercise comes at a crucial stage as India is poised to launch the first vaccines to the public. An expert panel from the central …
Read More »Coronavirus | Covaxin obtains panel approval from the central authority for restricted-use drugs
Bharat Biotech vaccine candidate approved for use in clinical trial mode. The first COVID-19 vaccine developed in India, Covaxin, has been recommended for “restricted use in emergency situations, subject to multiple regulatory conditions” by the Subject Matter Expert Committee (SEC) of the Central Medicines Control Organization ( CDSCO), here on …
Read More »Coronavirus | Central Medicines Authority panel recommends approval of Bharat Biotech’s Covaxin
Covaxin has been indigenously developed in collaboration with ICMR. An expert panel from India’s central drug authority recommended on January 2 to grant permission for the emergency restricted use of the locally developed COVID-19 vaccine Covaxin with certain conditions, a day after giving similar instructions for the COVID vaccine. -19 …
Read More »Oxford Covid vaccine approved, three more awaiting approval, confirms Javadekar | India News
NEW DELHI: India has given the green light to the Covid-19 vaccine developed by the University of Oxford-AstraZeneca and three other candidate vaccines are awaiting authorization for emergency use (USA), Union Minister Prakash Javadekar confirmed on Saturday . Sources had told TOI on Friday that the Indian drug regulator’s committee …
Read More »COVID-19 Vaccination: Who Will Get The COVID-19 Vaccine First, How To Register – Everything You Need To Know
COVID-19 vaccine: The vaccine will first be administered to around one million healthcare workers. New Delhi: The government plans to vaccinate 30 million people in India against the coronavirus in the next six to eight months, starting with frontline workers. A COVID-19 vaccination trial is taking place across the country …
Read More »A Covid-19 vaccination trial is underway; Health minister urges people not to heed rumors
Union Health Minister Dr Harsh Vardhan on Saturday urged people to “pay no heed to rumors” as the testing of Covid-19 vaccination began across the country. “I call on people not to pay attention to rumors. Ensuring the safety and efficacy of the vaccine is our priority. Different kinds of …
Read More »AstraZeneca expects to supply 20 doses of lakh vaccines per week in UK: report
Report comes after Britain approved Oxford-AstraZeneca’s COVID-19 vaccine Approximately two million doses of the COVID-19 vaccine developed by the University of Oxford and AstraZeneca will be delivered every week in mid-January in the UK, The Times reported. AstraZeneca expects to supply two million doses of the vaccine in total by …
Read More »Co-WIN App, Test Recipients: India Will Conduct Trial For Covid-19 Vaccination
India will hold a trial on Saturday before the actual vaccination campaign against the coronavirus disease (Covid-19) in an end-to-end exercise in which all steps will be tested in the states and territories of the Union. The activity will take place in all state capitals at at least three session …
Read More »All states will begin testing of the coronavirus vaccine today: 10 points
The Minister of Health will monitor the drill in the national capital. (Figurative) New Delhi: A trial will take place in every state today to verify the best way to vaccinate people against COVID-19 and to fill the gaps in logistics and training. This unit will also test the operational …
Read More »